Lataa...
Engineering Chimeric Antigen Receptors
Chimeric antigen receptors (CARs) are recombinant protein molecules that redirect cytotoxic lymphocytes toward malignant and other target cells. The high feasibility of manufacturing CAR-modified lymphocytes for the therapy of cancer has spurred the development and optimization of new CAR T cells di...
Tallennettuna:
| Julkaisussa: | Acta Naturae |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
A.I. Gordeyev
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406655/ https://ncbi.nlm.nih.gov/pubmed/28461969 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|